• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

揭示接受沙利度胺治疗的地中海贫血患者的隐匿性天然血型:5 个为什么分析法。

Unveiling the masked native blood group following thalidomide therapy in a thalassemia patient: A 5 WHY analysis approach.

机构信息

Department of Immunohematology & Blood Transfusion, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Department of General Medicine, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India.

出版信息

Transfus Apher Sci. 2022 Aug;61(4):103422. doi: 10.1016/j.transci.2022.103422. Epub 2022 Mar 12.

DOI:10.1016/j.transci.2022.103422
PMID:35305925
Abstract

Blood grouping discrepancy in patients with hematological disorders can occur due to red cell sensitization following transfusion, transplantation, and pregnancy or pre-analytical errors. Prompt initiation of root cause analysis is vital to avoid complications of wrong blood transfusion. We present an unusual case of Rh mismatched grouping report of 24 year old female thalassemia patient being managed in our hospital since 2015. Her current type and screen were observed as O Rh D negative with negative antibody screen while the historical blood group was O Rh D positive. The pre-analytical errors were ruled out and blood grouping performed from fresh sample also demonstrated as O Rh D negative despite antigen enhancement techniques and had no recent transfusion history. We sought to reason out the possibilities for discordant Rh grouping report, historical and present group through "Funnel based problem solving 5 WHY analysis" approach. The review of the past clinical history revealed that the patient had undergone Rh mismatch bone marrow transplant (Rh D positive donor and Rh D negative recipient) at 5 years of age which soon resulted in graft failure. Yet, she continued to receive Rh D positive blood thereafter with no development of anti-D which explains the historical blood group. Recently the patient was started on thalidomide, the Hb F inducer drug, which helped in maintaining her hemoglobin level between 9 and 10 g/dl without transfusion support for two months. This allowed unmasking of native Rh D negative blood and the review of clinical history played a significant role in resolution of grouping discrepancy.

摘要

在患有血液系统疾病的患者中,由于输血、移植和妊娠或分析前的错误导致红细胞致敏,可能会出现血型不合。及时启动根本原因分析对于避免错误输血的并发症至关重要。我们报告了一个不寻常的 Rh 血型不合的病例,患者为一名 24 岁女性地中海贫血患者,自 2015 年以来一直在我院接受治疗。她目前的血型和筛查结果为 O 型 Rh D 阴性,抗体筛查阴性,而既往的血型为 O 型 Rh D 阳性。排除了分析前的错误,对新鲜样本进行的血型鉴定也显示为 O 型 Rh D 阴性,尽管使用了抗原增强技术,且患者最近没有输血史。我们试图通过“基于漏斗的问题解决 5 个为什么分析”方法来找出不一致的 Rh 血型报告、既往和现在的血型之间的可能性。回顾过去的临床病史显示,患者在 5 岁时接受了 Rh 不合的骨髓移植(Rh D 阳性供体和 Rh D 阴性受者),随后很快发生移植物失败。然而,此后她继续接受 Rh D 阳性血液输注,并未产生抗-D,这解释了既往的血型。最近,患者开始服用沙利度胺,这是一种 HbF 诱导药物,使她的血红蛋白水平在 9 到 10g/dl 之间维持了两个月,无需输血支持。这揭示了患者的固有 Rh D 阴性血型,临床病史的回顾在解决血型鉴定差异方面发挥了重要作用。

相似文献

1
Unveiling the masked native blood group following thalidomide therapy in a thalassemia patient: A 5 WHY analysis approach.揭示接受沙利度胺治疗的地中海贫血患者的隐匿性天然血型:5 个为什么分析法。
Transfus Apher Sci. 2022 Aug;61(4):103422. doi: 10.1016/j.transci.2022.103422. Epub 2022 Mar 12.
2
Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.巴基斯坦定期输血的β地中海贫血患者中的红细胞同种免疫
Transfus Med. 2015 Apr;25(2):106-10. doi: 10.1111/tme.12196. Epub 2015 Apr 14.
3
Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications.镰状细胞病、地中海贫血及其他输血并发症的红细胞抗原基因分型
Transfus Med Rev. 2016 Oct;30(4):197-201. doi: 10.1016/j.tmrv.2016.05.011. Epub 2016 May 28.
4
Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation.血型不相合骨髓移植患者的血液疗法
Transfusion. 1983 Jul-Aug;23(4):277-85. doi: 10.1046/j.1537-2995.1983.23483276858.x.
5
Optimal blood grouping and antibody screening for safe transfusion.安全输血的最佳血型鉴定与抗体筛查。
Prilozi. 2009 Jul;30(1):119-28.
6
Rh antibodies against the pretransplant red cells following Rh-incompatible bone marrow transplantation.Rh不相合骨髓移植后针对移植前红细胞的Rh抗体。
Transfusion. 1988 May-Jun;28(3):272-5. doi: 10.1046/j.1537-2995.1988.28388219159.x.
7
The value of transfusion of phenotyped blood units for thalassemia and sickle cell anemia patients at an academic center.在学术中心,为地中海贫血症和镰状细胞贫血症患者输注表型血液单位的价值。
Transfusion. 2020 Feb;60 Suppl 1:S15-S21. doi: 10.1111/trf.15682.
8
Anti-D alloimmunization in Rh(D) negative adults with severe traumatic injury.严重创伤成年 Rh(D)阴性患者的抗-D 同种免疫。
Transfusion. 2021 Jul;61 Suppl 1:S144-S149. doi: 10.1111/trf.16493.
9
Developing a databank for multiple transfusion patients: Rh antigen and phenotype distribution among 3000 regular blood donors in Iran.建立一个多输血患者数据库:伊朗 3000 名常规献血者中的 Rh 抗原和表型分布。
Transfus Apher Sci. 2021 Jun;60(3):103124. doi: 10.1016/j.transci.2021.103124. Epub 2021 Apr 2.
10
Loss and Reappearance of A Antigen After Chemotherapy Leading to Blood Group Discrepancy in Acute Myeloid Leukemia: A Case Report.化疗后A抗原的丢失与重现导致急性髓系白血病血型不符:一例报告
Lab Med. 2021 Sep 1;52(5):509-513. doi: 10.1093/labmed/lmab008.